Skip to main content

Find opportunities for you and your members to save

Optimizing medications, or removing unnecessary duplicate therapies, helps members stay healthier and reduces costs. Drug Savings Review quickly locates these opportunities so providers can decide what’s best for their patients.

Get in touch

Medication on shelves

Save with evidence-based outreach

Using robust data, we identify members who might be at risk and provide voluntary recommendations to prescribers so they can make informed decisions that better support members.

Helping members on medication therapy stay healthier

Utilizing technology for timely results

Unique, advanced algorithms review prescription claims within 72 hours to find opportunities for safer, more cost-effective therapies that help members stay healthier.

Family members interact

Prioritizing safety and value

Recommendations are sent directly to prescribers before the member’s next refill, making sure any changes are considered by the provider first, not the member.

Provider checks information

Continuous care and support

If the provider accepts the recommended change, you save. If no changes are made, members continue to receive their medications as prescribed, all without disruption.

Pharmacist speaks to customer

Contact us

Want to spend less and inspire healthier members?
Let us help you find the best solutions. 

 

Get in touch


  • *FOR 1.25% SAVINGS ON ANNUAL TOTAL DRUG SPEND SOURCE: Data that was used was sourced from our 2024 iTools reporting and overall spend by the carrier for 2024. Represents employer clients with Drug Savings Review in 2023 and 2024, exclusive of outliers. (Outliers is defined as clients whose member totals were less than 5,000 and interventions count was less than 100 or client spend was less than $1,000,000) Actual results may vary depending on benefit plan design, member demographics, programs implemented by the plan and other factors.


     

  • *FOR 2:1 GUARANTEED MINIMUM ROI SOURCE: CVS Health®. CVS Health Analytics. Data that was used was sourced from our 2024 iTools reporting and overall spend by the carrier for 2024. Represents employer clients with Drug Savings Review in 2023 and 2024, exclusive of outliers. (Outliers is defined as clients whose member totals were less than 5,000 and interventions count was less than 100 or client spend was less than $1,000,000) Actual results may vary depending on benefit plan design, member demographics, programs implemented by the plan and other factors.